NCT04661657View on ClinicalTrials.gov

COvid-19 LongitUdinal Multiethnic BioImaging Assessment of CARDiovascular Sequelae Registry

CompletedOBSERVATIONAL
Enrollment

52

Participants

Timeline

Start Date

December 28, 2020

Primary Completion Date

January 22, 2022

Study Completion Date

January 22, 2022

Conditions
Covid19Cardiac DiseaseCardiac ArrhythmiaMyocarditisLeft Ventricular Dysfunction
Interventions
OTHER

Transthoracic echocardiogram (TTE)

Subjects will undergo TTE imaging.

OTHER

Cardiovascular Magnetic Resonance (CMR) Imaging

Subjects will undergo CMR Imaging using a gadolinium based contrast agent (GBCA).

Trial Locations (1)

10032

Columbia University Irving Medical Center, New York

Sponsors

Collaborators (1)

GE Healthcare
All Listed Sponsors
collaborator

GE Healthcare

INDUSTRY

lead

Columbia University

OTHER

NCT04661657 - COvid-19 LongitUdinal Multiethnic BioImaging Assessment of CARDiovascular Sequelae Registry | Biotech Hunter | Biotech Hunter